Trials / Completed
CompletedNCT03671941
Clinical Study to Compare the Pharmacokinetic Characteristics and Safety Between CKD-357 and D578 in Healthy Volunteers
A Randomized, Open-label, Single Dose, Crossover Study to Evaluate Pharmacokinetic Profiles and Safety/Tolerability of CKD-357 in Healthy Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 31 (actual)
- Sponsor
- Chong Kun Dang Pharmaceutical · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Accepted
Summary
A randomized, open-label, single dose, crossover study to evaluate pharmacokinetic profiles and safety/tolerability of CKD-357 in healthy volunteers
Detailed description
To healthy subjects of thirty(30), following treatments are administered dosing in each period and wash-out period is a minimum of 7 days.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | D578 | D578 Tab.1T single oral administration under fasting condition |
| DRUG | CKD-357 | CKD-357 Tab.1T single oral administration under fasting condition |
Timeline
- Start date
- 2018-05-25
- Primary completion
- 2018-06-04
- Completion
- 2018-06-18
- First posted
- 2018-09-14
- Last updated
- 2018-09-19
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT03671941. Inclusion in this directory is not an endorsement.